Hygeia Healthcare Holdings Co., Limited (HYGEIA HEALTH) disclosed in a Next Day Disclosure Return filed with the Hong Kong Stock Exchange on 21 September 2026 that it repurchased 10,800 ordinary shares on-market the same day.

The shares were bought at prices ranging from HKD 9.69 to HKD 9.75, translating into a volume-weighted average cost of HKD 9.71 per share and an aggregate outlay of HKD 0.10 million. All repurchased shares have been retained as treasury stock.

Post-transaction, HYGEIA HEALTH’s issued share capital (excluding treasury shares) fell marginally to 603.65 million, down 0.0018%. Treasury shares increased to 14.85 million, while the company’s total issued shares remained unchanged at 618.50 million because the repurchased shares have not been cancelled.

Since the current share-repurchase mandate was approved on 26 June 2026, the company has bought back 4.09 million shares, representing 0.67% of the total shares outstanding at the mandate date. The mandate allows repurchases of up to 60.77 million shares.

In accordance with Hong Kong listing rules, HYGEIA HEALTH is subject to a moratorium on issuing new shares or disposing of treasury shares until 21 October 2026.